236 related articles for article (PubMed ID: 18789829)
1. Inter- and intraobserver variation in HR-CTV contouring: intercomparison of transverse and paratransverse image orientation in 3D-MRI assisted cervix cancer brachytherapy.
Petric P; Dimopoulos J; Kirisits C; Berger D; Hudej R; Pötter R
Radiother Oncol; 2008 Nov; 89(2):164-71. PubMed ID: 18789829
[TBL] [Abstract][Full Text] [Related]
2. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology.
Pötter R; Haie-Meder C; Van Limbergen E; Barillot I; De Brabandere M; Dimopoulos J; Dumas I; Erickson B; Lang S; Nulens A; Petrow P; Rownd J; Kirisits C;
Radiother Oncol; 2006 Jan; 78(1):67-77. PubMed ID: 16403584
[TBL] [Abstract][Full Text] [Related]
3. Inter-observer comparison of target delineation for MRI-assisted cervical cancer brachytherapy: application of the GYN GEC-ESTRO recommendations.
Dimopoulos JC; De Vos V; Berger D; Petric P; Dumas I; Kirisits C; Shenfield CB; Haie-Meder C; Pötter R
Radiother Oncol; 2009 May; 91(2):166-72. PubMed ID: 19062118
[TBL] [Abstract][Full Text] [Related]
4. Intercomparison of treatment concepts for MR image assisted brachytherapy of cervical carcinoma based on GYN GEC-ESTRO recommendations.
Lang S; Nulens A; Briot E; Kirisits C; De Brabandere M; Dumas I; Dimopoulos J; Petrow P; Georg D; Van Limbergen E; Haie-Meder C; Pötter R
Radiother Oncol; 2006 Feb; 78(2):185-93. PubMed ID: 16466820
[TBL] [Abstract][Full Text] [Related]
5. A dose-volume analysis of magnetic resonance imaging-aided high-dose-rate image-based interstitial brachytherapy for uterine cervical cancer.
Yoshida K; Yamazaki H; Takenaka T; Kotsuma T; Yoshida M; Furuya S; Tanaka E; Uegaki T; Kuriyama K; Matsumoto H; Yamada S; Ban C
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):765-72. PubMed ID: 19836165
[TBL] [Abstract][Full Text] [Related]
6. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV.
Haie-Meder C; Pötter R; Van Limbergen E; Briot E; De Brabandere M; Dimopoulos J; Dumas I; Hellebust TP; Kirisits C; Lang S; Muschitz S; Nevinson J; Nulens A; Petrow P; Wachter-Gerstner N;
Radiother Oncol; 2005 Mar; 74(3):235-45. PubMed ID: 15763303
[TBL] [Abstract][Full Text] [Related]
7. Determining DVH parameters for combined external beam and brachytherapy treatment: 3D biological dose adding for patients with cervical cancer.
Van de Kamer JB; De Leeuw AA; Moerland MA; Jürgenliemk-Schulz IM
Radiother Oncol; 2010 Feb; 94(2):248-53. PubMed ID: 20080309
[TBL] [Abstract][Full Text] [Related]
8. From point A to the sculpted pear: MR image guidance significantly improves tumour dose and sparing of organs at risk in brachytherapy of cervical cancer.
Tanderup K; Nielsen SK; Nyvang GB; Pedersen EM; Røhl L; Aagaard T; Fokdal L; Lindegaard JC
Radiother Oncol; 2010 Feb; 94(2):173-80. PubMed ID: 20138380
[TBL] [Abstract][Full Text] [Related]
9. Consequences of random and systematic reconstruction uncertainties in 3D image based brachytherapy in cervical cancer.
Tanderup K; Hellebust TP; Lang S; Granfeldt J; Pötter R; Lindegaard JC; Kirisits C
Radiother Oncol; 2008 Nov; 89(2):156-63. PubMed ID: 18692265
[TBL] [Abstract][Full Text] [Related]
10. Applicator reconstruction and applicator shifts in 3D MR-based PDR brachytherapy of cervical cancer.
De Leeuw AA; Moerland MA; Nomden C; Tersteeg RH; Roesink JM; Jürgenliemk-Schulz IM
Radiother Oncol; 2009 Nov; 93(2):341-6. PubMed ID: 19515443
[TBL] [Abstract][Full Text] [Related]
11. Controversies and new developments in gynecologic brachytherapy: image-based intracavitary brachytherapy for cervical carcinoma.
Nag S
Semin Radiat Oncol; 2006 Jul; 16(3):164-7. PubMed ID: 16814157
[TBL] [Abstract][Full Text] [Related]
12. Applicator reconstruction in MRI 3D image-based dose planning of brachytherapy for cervical cancer.
Haack S; Nielsen SK; Lindegaard JC; Gelineck J; Tanderup K
Radiother Oncol; 2009 May; 91(2):187-93. PubMed ID: 18977049
[TBL] [Abstract][Full Text] [Related]
13. Transrectal ultrasound for image-guided adaptive brachytherapy in cervix cancer - An alternative to MRI for target definition?
Schmid MP; Nesvacil N; Pötter R; Kronreif G; Kirisits C
Radiother Oncol; 2016 Sep; 120(3):467-472. PubMed ID: 26921168
[TBL] [Abstract][Full Text] [Related]
14. Present status and future of high-precision image guided adaptive brachytherapy for cervix carcinoma.
Potter R; Kirisits C; Fidarova EF; Dimopoulos JC; Berger D; Tanderup K; Lindegaard JC
Acta Oncol; 2008; 47(7):1325-36. PubMed ID: 18661430
[TBL] [Abstract][Full Text] [Related]
15. Image-guided cervix high-dose-rate brachytherapy treatment planning: does custom computed tomography planning for each insertion provide better conformal avoidance of organs at risk?
Davidson MT; Yuen J; D'Souza DP; Batchelar DL
Brachytherapy; 2008; 7(1):37-42. PubMed ID: 18299111
[TBL] [Abstract][Full Text] [Related]
16. MRI-guided 3D optimization significantly improves DVH parameters of pulsed-dose-rate brachytherapy in locally advanced cervical cancer.
Lindegaard JC; Tanderup K; Nielsen SK; Haack S; Gelineck J
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):756-64. PubMed ID: 18191335
[TBL] [Abstract][Full Text] [Related]
17. Variation of treatment planning parameters (D90 HR-CTV, D 2cc for OAR) for cervical cancer tandem ring brachytherapy in a multicentre setting: comparison of standard planning and 3D image guided optimisation based on a joint protocol for dose-volume constraints.
Jürgenliemk-Schulz IM; Lang S; Tanderup K; de Leeuw A; Kirisits C; Lindegaard J; Petric P; Hudej R; Pötter R;
Radiother Oncol; 2010 Mar; 94(3):339-45. PubMed ID: 19944471
[TBL] [Abstract][Full Text] [Related]
18. Proposed guidelines for image-based intracavitary brachytherapy for cervical carcinoma: report from Image-Guided Brachytherapy Working Group.
Nag S; Cardenes H; Chang S; Das IJ; Erickson B; Ibbott GS; Lowenstein J; Roll J; Thomadsen B; Varia M;
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1160-72. PubMed ID: 15519788
[TBL] [Abstract][Full Text] [Related]
19. Dose-effect relationship for local control of cervical cancer by magnetic resonance image-guided brachytherapy.
Dimopoulos JC; Pötter R; Lang S; Fidarova E; Georg P; Dörr W; Kirisits C
Radiother Oncol; 2009 Nov; 93(2):311-5. PubMed ID: 19679365
[TBL] [Abstract][Full Text] [Related]
20. High-risk CTV delineation for cervix brachytherapy: Application of GEC-ESTRO guidelines in Australia and New Zealand.
Vinod SK; Lim K; Bell L; Veera J; Ohanessian L; Juresic E; Borok N; Chan P; Chee R; Do V; Govindarajulu G; Sridharan S; Johnson C; Moses D; Van Dyk S; Holloway L
J Med Imaging Radiat Oncol; 2017 Feb; 61(1):133-140. PubMed ID: 27527506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
